News - Page 8

UiO:Life Science welcomes you to the Oslo Life Science Conference – Building the Life Science City – 15th–17th February 2017.

We have hosted life science lunches on innovation, epigenetics, gene editing and cancer and stem cells in 2016. Watch the recordings of the seminars.

UiO:Life Science is one of three large interdisciplinary strategic areas at UiO. Our strategy states that we shall strengthen quality and interaction in research; recruit, educate and develop talents; and promote innovation in the life sciences related to environment and health. A life sciences building, which is planned for completion in 2023, is a significant aspect of our work.

Researchers at the Faculty have shown that harmful immune cells are more easily activated in patients suffering from the autoimmune disease lupus than in healthy people.

Interactions between the gut and the body are central to good health. Researchers at the University of Oslo have now identified one of the key regulators of these interactions.

Using low sun protection factor may increase the risk of melanoma. Cutaneous melanoma is one of the most rapidly increasing cancers in Norway and is becoming a major public health challenge.

Quality assurance of the management base and cost estimates before the project is submitted to Parliament for approval and funding (QA2) of the planned life science building at UiO started August 16th according to the time schedule and is to be finished till Christmas.

At the 14th and 15th  of September the Nordic Life Science Days is arranged in Stockholm. In the evening the 13th a Norwegian–Swedish networking is taking place at the Norwegian Embassy in Stockholm.

The Neanderthals lacked several of the genes that can lead to schizophrenia. Does this mean that the genes for schizophrenia are linked to what makes the human species so successful?

Three out of four people could avoid knee surgery with a new form of exercise therapy, with significant cost savings for society.

The director for UiO:Life Science, Finn-Eirik Johansen, has established an advisory management team and hired Morten Egeberg as the administrative leader for UiO:Life Science.

Join a virtual tour in the planned life sciences building at UiO. Watch the tour in 3D on your smartphone using VR glasses.

It is well known that the drug ASA, also known internationally as Aspirin, has analgesic and fever-reducing properties. However, this drug may also increase the likelihood of surviving colon cancer.

The immune defence systems of healthy individuals may become key to future cancer treatment.

Can knowledge about one disease help us to find treatment for another disease?

Together with an international research group, Bente Halvorsen, Professor of Medicine at the University of Oslo, has found a new and effective way to treat hardening of the arteries. The idea came from an unexpected source.

“Oh, you're so hormonal!". We all understand what that means: moody and volatile. But hormones do much more than influence our mood. Without hormones our bodies simply would not function.

British Reuters visited the research group of Professor Pål Rongved at the School of Pharmacy and has made a video about the group's cutting edge technology against antibiotic-resistant bacteria.

Nature or nurture? Epigenetics is about how both genes and the environment shape us and make us who we are. Doctoral research fellow Ellen Wikenius wanted to make her field more widely accessible. The animated film "Epigenetics: nurture vs nature" is now ready.

Researchers at UiO and NCMM have discovered that the system used by bacteria to transport magnesium is so sensitive that it can detect a pinch of magnesium salt in a swimming pool. 

The researcher Geir Åge Løset established the company Nextera on the basis of his own research at UiO. He believes that innovation is a state of mind that needs to be inculcated from the very start of studies. Nextera’s groundbreaking technology facilitates the development of new, targeted drugs that can treat chronic inflammatory and autoimmune diseases with fewer side effects, and thereby benefit society considerably.

‘To reach the stage of a clinical trial is exciting and challenging, and such a huge step,’ says Agnete B. Fredriksen, Chief Scientific Officer at Vaccibody, as she describes the process of taking her vaccine research further to a company that tests its products on humans and has built up a network of global partners.

Researchers at the institute are developing an app that can help spread new and credible knowledge.

24 pictures give you an insight into the everyday work of life sciences researchers at UiO and UiO’s work related to the priority area UiO:Life Science.

UiO has many life sciences researchers who are working to discover how the brain develops throughout the lifespan and what are the underlying causes of brain disease.